Characterization of the anticollagen antibody response in a new model of chronic polyarthritis

Arthritis and Rheumatism

Volumn 63, Issue 8, 2011, Pages 2299-2308

  Conigliaro, Paola ^a   Benson, Robert A ^b   Patakas, Agapitos ^b   Kelly, Sharon M ^b   Valesini, Guido ^c   Holmdahl, Rikard ^d   Brewer, James M ^b   McInnes, Iain B ^b   Garside, Paul ^b  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c KAROLINSKA INSTITUTE   (Sweden)

^d UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 2; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; OVALBUMIN;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY AFFINITY; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CHRONIC ARTHRITIS; COLLAGEN INDUCED ARTHRITIS; CONTROLLED STUDY; FEMALE; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; TH1 CELL;

ANIMALS; ARTHRITIS, EXPERIMENTAL; AUTOANTIBODIES; AUTOIMMUNE DISEASES; AUTOIMMUNITY; B-LYMPHOCYTES; COLLAGEN TYPE II; DISEASE MODELS, ANIMAL; FEMALE; MICE;

EID: 79961117919     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.30413     Document Type: Article

References (43)

1. Firestein GS,. Rheumatoid synovitis and pannus. In:, Klippel JH, Dieppe PA, editors. Rheumatology. 2nd ed. Vol 1. London: Mosby; 1998. p. 13.1-.24.
2. Panayi GS,. B cells: a fundamental role in the pathogenesis of rheumatoid arthritis? Rheumatology (Oxford) 2005; 44 Suppl 2: ii3-7.
3. Senolt L, Vencovsky J, Pavelka K, Ospelt C, Gay S,. Prospective new biological therapies for rheumatoid arthritis. Autoimmun Rev 2009; 9: 102-7.
4. Dorner T, Burmester GR,. New approaches of B-cell-directed therapy: beyond rituximab. Curr Opin Rheumatol 2008; 20: 263-8. (Pubitemid 351483314)
5. Eisenberg R, Albert D,. B-cell targeted therapies in rheumatoid arthritis and systemic lupus erythematosus. Nat Clin Pract Rheumatol 2006; 2: 20-7. (Pubitemid 43153645)
6. Roosnek E, Lanzavecchia A,. Efficient and selective presentation of antigen-antibody complexes by rheumatoid factor B cells. J Exp Med 1991; 173: 487-9.
7. Rantapaa-Dahlqvist S, de Jong BA, Berglin E, Hallmans G, Wadell G, Stenlund H, et al. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum 2003; 48: 2741-9. (Pubitemid 37280601)
8. Nielen MM, van Schaardenburg D, Reesink HW, van de Stadt RJ, van der Horst-Bruinsma IE, de Koning MH, et al. Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum 2004; 50: 380-6. (Pubitemid 38198821)
9. Reparon-Schuijt CC, van Esch WJ, van Kooten C, Schellekens GA, de Jong BA, van Venrooij WJ, et al. Secretion of anti-citrulline-containing peptide antibody by B lymphocytes in rheumatoid arthritis. Arthritis Rheum 2001; 44: 41-7. (Pubitemid 32113116)
10. Masson-Bessiere C, Sebbag M, Durieux JJ, Nogueira L, Vincent C, Girbal-Neuhauser E, et al. In the rheumatoid pannus, anti-filaggrin autoantibodies are produced by local plasma cells and constitute a higher proportion of IgG than in synovial fluid and serum. Clin Exp Immunol 2000; 119: 544-52. (Pubitemid 30146353)
11. Rosenstein ED, Greenwald RA, Kushner LJ, Weissmann G,. Hypothesis: the humoral immune response to oral bacteria provides a stimulus for the development of rheumatoid arthritis. Inflammation 2004; 28: 311-8. (Pubitemid 41504274)
12. De Pablo P, Dietrich T, McAlindon TE,. Association of periodontal disease and tooth loss with rheumatoid arthritis in the US population. J Rheumatol 2008; 35: 70-6.
13. Cho YG, Cho ML, Min SY, Kim HY,. Type II collagen autoimmunity in a mouse model of human rheumatoid arthritis. Autoimmun Rev 2007; 7: 65-70.
14. Rowley MJ, Williamson DJ, Mackay IR,. Evidence for local synthesis of antibodies to denatured collagen in the synovium in rheumatoid arthritis. Arthritis Rheum 1987; 30: 1420-5. (Pubitemid 18051915)
15. Tarkowski A, Klareskog L, Carlsten H, Herberts P, Koopman WJ,. Secretion of antibodies to types I and II collagen by synovial tissue cells in patients with rheumatoid arthritis. Arthritis Rheum 1989; 32: 1087-92. (Pubitemid 19237862)
16. Burkhardt H, Koller T, Engstrom A, Nandakumar KS, Turnay J, Kraetsch HG, et al. Epitope-specific recognition of type II collagen by rheumatoid arthritis antibodies is shared with recognition by antibodies that are arthritogenic in collagen-induced arthritis in the mouse. Arthritis Rheum 2002; 46: 2339-48.
17. Londei M, Savill CM, Verhoef A, Brennan F, Leech ZA, Duance V, et al. Persistence of collagen type II-specific T-cell clones in the synovial membrane of a patient with rheumatoid arthritis. Proc Natl Acad Sci U S A 1989; 86: 636-40. (Pubitemid 19037795)
18. Stuart JM, Dixon FJ,. Serum transfer of collagen-induced arthritis in mice. J Exp Med 1983; 158: 378-92. (Pubitemid 13049395)
19. Holmdahl R, Rubin K, Klareskog L, Larsson E, Wigzell H,. Characterization of the antibody response in mice with type II collagen-induced arthritis, using monoclonal anti-type II collagen antibodies. Arthritis Rheum 1986; 29: 400-10. (Pubitemid 16127275)
20. Bajtner E, Nandakumar KS, Engstrom A, Holmdahl R,. Chronic development of collagen-induced arthritis is associated with arthritogenic antibodies against specific epitopes on type II collagen. Arthritis Res Ther 2005; 7: R1148-57.
21. Nandakumar KS, Bajtner E, Hill L, Bohm B, Rowley MJ, Burkhardt H, et al. Arthritogenic antibodies specific for a major type II collagen triple-helical epitope bind and destabilize cartilage independent of inflammation. Arthritis Rheum 2008; 58: 184-96.
22. Nandakumar KS, Svensson L, Holmdahl R,. Collagen type II-specific monoclonal antibody-induced arthritis in mice: description of the disease and the influence of age, sex, and genes. Am J Pathol 2003; 163: 1827-37. (Pubitemid 37310014)
23. Kraetsch HG, Unger C, Wernhoff P, Schneider C, Kalden JR, Holmdahl R, et al. Cartilage-specific autoimmunity in rheumatoid arthritis: characterization of a triple helical B cell epitope in the integrin-binding-domain of collagen type II. Eur J Immunol 2001; 31: 1666-73. (Pubitemid 32547328)
24. Maffia P, Brewer JM, Gracie JA, Ianaro A, Leung BP, Mitchell PJ, et al. Inducing experimental arthritis and breaking self-tolerance to joint-specific antigens with trackable, ovalbumin-specific T cells. J Immunol 2004; 173: 151-6. (Pubitemid 38797336)
25. Jongbloed SL, Benson RA, Nickdel MB, Garside P, McInnes IB, Brewer JM,. Plasmacytoid dendritic cells regulate breach of self-tolerance in autoimmune arthritis. J Immunol 2009; 182: 963-8.
26. Nickdel MB, Conigliaro P, Valesini G, Hutchison S, Benson R, Bundick RV, et al. Dissecting the contribution of innate and antigen-specific pathways to the breach of self-tolerance observed in a murine model of arthritis. Ann Rheum Dis 2009; 68: 1059-66.
27. lo thymocytes in vivo. Science 1990; 250: 1720-3. (Pubitemid 120031881)
28. + T cells provide help for B cell clonal expansion and antibody synthesis in a similar manner in vivo. J Immunol 2000; 165: 3136-44.
29. Joosten LA, Lubberts E, Durez P, Helsen MM, Jacobs MJ, Goldman M, et al. Role of interleukin-4 and interleukin-10 in murine collagen-induced arthritis: protective effect of interleukin-4 and interleukin-10 treatment on cartilage destruction. Arthritis Rheum 1997; 40: 249-60. (Pubitemid 27114088)
30. Uysal H, Bockermann R, Nandakumar KS, Sehnert B, Bajtner E, Engstrom A, et al. Structure and pathogenicity of antibodies specific for citrullinated collagen type II in experimental arthritis. J Exp Med 2009; 206: 449-62.
31. Karlsson R, Mo JA, Holmdahl R,. Binding of autoreactive mouse anti-type II collagen antibodies derived from the primary and the secondary immune response investigated with the biosensor technique. J Immunol Methods 1995; 15; 188: 63-71. (Pubitemid 26011535)
32. Leonard P, Safsten P, Hearty S, McDonnell B, Finlay W, O'Kennedy R,. High throughput ranking of recombinant avian scFv antibody fragments from crude lysates using the Biacore A100. J Immunol Methods 2007; 323: 172-9. (Pubitemid 46890968)
33. Holmdahl R, Vingsbo C, Mo JA, Michaelsson E, Malmstrom V, Jansson L, et al. Chronicity of tissue-specific experimental autoimmune disease: a role for B cells? Immunol Rev 1995; 144: 109-35.
34. Park S, Rath O, Beach S, Xiang X, Kelly SM, Luo Z, et al. Regulation of RKIP binding to the N-region of the Raf-1 kinase. FEBS Lett 2006; 580: 6405-12. (Pubitemid 44750928)
35. Holmdahl R, Vingsbo C, Malmstrom V, Jansson L, Holmdahl M,. Chronicity of arthritis induced with homologous type II collagen (CII) in rats is associated with anti-CII B-cell activation. J Autoimmun 1994; 7: 739-52. (Pubitemid 24378359)
36. Svensson L, Jirholt J, Holmdahl R, Jansson L,. B cell-deficient mice do not develop type II collagen-induced arthritis (CIA). Clin Exp Immunol 1998; 111: 521-6. (Pubitemid 28160894)
37. McInnes IB, Schett G,. Cytokines in the pathogenesis of rheumatoid arthritis. Nat Rev Immunol 2007; 7: 429-42. (Pubitemid 46834849)
38. Wooley PH, Chapedelaine JM,. Immunogenetics of collagen-induced arthritis. Crit Rev Immunol 1987; 8: 1-22.
39. Nandakumar KS, Holmdahl R,. Efficient promotion of collagen antibody induced arthritis (CAIA) using four monoclonal antibodies specific for the major epitopes recognized in both collagen induced arthritis and rheumatoid arthritis. J Immunol Methods 2005; 304: 126-36. (Pubitemid 41262227)
40. Terato K, Hasty KA, Reife RA, Cremer MA, Kang AH, Stuart JM,. Induction of arthritis with monoclonal antibodies to collagen. J Immunol 1992; 148: 2103-8.
41. Benson RA, Patakas A, Conigliaro P, Rush CM, Garside P, McInnes IB, et al. Identifying the cells breaching self-tolerance in autoimmunity. J Immunol 2010; 184: 6378-85
42. Rudolphi U, Rzepka R, Batsford S, Kaufmann SH, von der Mark K, Peter HH, et al. The B cell repertoire of patients with rheumatoid arthritis. II. Increased frequencies of IgG+ and IgA+ B cells specific for mycobacterial heat-shock protein 60 or human type II collagen in synovial fluid and tissue. Arthritis Rheum 1997; 40: 1409-19. (Pubitemid 27430951)
43. Kim HY, Kim WU, Cho ML, Lee SK, Youn J, Kim SI, et al. Enhanced T cell proliferative response to type II collagen and synthetic peptide CII (255-274) in patients with rheumatoid arthritis. Arthritis Rheum 1999; 42: 2085-93. (Pubitemid 30263591)